Member Info for Vander

The large company MTA is doing very early work- large gene delivery is not what the current version of nuvec is optimised and intended for
It’s positive that they have expressed interest but small projects taking 9 months for a few thousand quid are no good unless it leads to a long term commitment with the intention to reach human trials with associated milestone payments- who knows- let’s see

The results have been delayed 6 months- the initial formulation did not perform well- neither did the control- the optimised version may do

There are various avenues along which this could progress- a covid vaccine delivered by injection is not one of them- it will be a few years too late

The results in December will be important but still only a small milestone- there are now lots of dna vaccines in development worldwide and some much more advanced. They will need to work on marginal gains in efficacy with the nanomerics formulation but not compromise safety, with manufacture at scale, with the plasmid provider and decide on the disease indication and even delivery method. The use of large genes, rna, proteins such as TNF are completely different routes

If the December results are very positive - and comparative with other vaccines in human trials-it means that they is a route to develop with plasmid dna, although a covid vaccine is miles off. They will need much more investment and scientific input to get off the ground

Companies face very high corruption risks when dealing with the Congolese public procurement sector. There is an absence of transparency of governmental decisions, and accountability when it comes to public contracting (BTI 2016). In fact, public procurement decisions and privatization deals are generally based on political considerations, rather than economic ones (BTI 2016). Over half of all surveyed business executives expected to give gifts to officials to secure government contracts (ES 2013). Monopolies and cartels dominate the market, and are generally associated with people from the president’s inner circle, rendering fair competition nonexistent (BTI 2016).

Aiming- in addition to signing a contract, they need to make profit

WSG have never achieved that

Foxy are you saying that the basis for the queens award was the DRC contract? I thought it was thrown in with the Tower of London/ Houses of Parliament contract, in return for a 50% discount

At the time of the reverse takeover of onzima, N4p had 7 patent families for each reformulation respectively - for sidenafil alone there were 45 pending uk patents.

Fowler’s time horizon is in decades
In 2012 he said ‘judge me in ten years’ not in months- that will only pander to traders

Ultimately we need a big company backer- that’s likely to be in uk or Europe (not China)

An important judgement is whether the last profitless 9 years were an aberrant state and can be rehabilitated from or alternatively whether the fowler clan are a long-standing curse/trait whose culture and practice prioritise operational and employees wellbeing over that of profit/ shareholders

Fowler does this a lot- appeases shareholders with short term targets which are always over optimistic- despite his experience he has no ability to gauge outcomes accurately- either that or he just lies alot and believes that it does not matter

How reliable is Arden research and predictions on WSG? Any better than posts on here?
If they get it wrong are there any consequences/accountability?

Foxy: fowler is no mug
He is well aware that appointment of a new ceo would risk the subtle marginalisation and then sacking of Joanna and Stuart, under the guise that they need more time to be with their family. He has no qualms robbing/diluting dumb shareholders- but family is different

Will Vincent will be next CEO?

I should have dated my post to Dec 20- dilution over 100% since then- I would have thought it was obvious, but happy to clarify

Target- Are you saying that the December (2020) placing increased the number of shares by 15% or are you referring to dilution only during 2021?

Nigel is keeping the detail of the Large company MTA up his sleeve
The aim here is to secure funds, expertise and patience from a big backer- although small £63k projects funded by the government, over 9 months, in collaboration with Medimmune are better than nothing

Slow progress- ongoing optimisation and early stage clarification on how it may be used
no mention of USA patent? or recognition of first dna covid intradermal vaccine.
The MTAs are interesting- but no new detail

The SP has more doubled once dilution accounted for- fowler will be satisfied- the market/ thousands of watchers has researched and is fully appraised of DRC and the likely WSG business trajectory. It’s not the mystery some like to claim

Fowler runs the casino- it’s the punters who pay